Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02747862 · ClinicalTrials.gov registry record

Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program

A clinical trial of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
1,500
Enrollment target
1
Study location

NCT02747862 is a study of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02747862, a study of Attenuated Familial Adenomatous Polyposis and Deleterious Familial Adenomatous Polyposis, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this chart review study is to evaluate the outcomes of subjects with Attenuated Familial Adenomatous Polyposis (AFAP) and Deleterious Familial Adenomatous Polyposis (FAP) who have not undergone surgical resection of the colon. A secondary objective of this study is to compare 1) the colonoscopic and pathology histories including history of ampullary adenoma in the duodenum over family generations, 2) the use of chemopreventive medications, and 3) clinical features of subjects who pursued prophylactic surgical resection of the colon with those that have elected to continue routine colonoscopic surveillance in an effort to better characterize factors (e.g. polyp burden, ampullary adenoma and level of dysplasia, etc) which may influence management decisions.

Interventions

  • OTHER Chart Review

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2008-02
Est. Completion 2022-08-17

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02747862

The ClinicalTrials.gov registry entry for NCT02747862 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Attenuated Familial Adenomatous Polyposis appearing as the primary indexed condition, and to 1 intervention - of which Chart Review is the first listed.

NCT02747862 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02747862 about?

NCT02747862 is a clinical study titled "Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program". The primary objective of this chart review study is to evaluate the outcomes of subjects with Attenuated Familial Adenomatous Polyposis (AFAP) and Deleterious Familial Adenomatous Polyposis (FAP) who have not undergone surgical resection of the colon. A secondary objective of this study is to compa...

What is the current status of trial NCT02747862?

This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2008-02. Estimated completion is 2022-08-17.

What conditions does trial NCT02747862 study?

This clinical trial studies the following conditions: Attenuated Familial Adenomatous Polyposis, Deleterious Familial Adenomatous Polyposis.

What interventions are being tested in trial NCT02747862?

The interventions under investigation include: Chart Review (OTHER).

Who is sponsoring clinical trial NCT02747862?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02747862 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.